Therapeutic combinations of anti-cd20 and anti-gm-csf antibodies and uses thereof
AssigneeMorphosys AG
InventorStefan Steidl
Life of this patent
Estimating the term…
Abstract
The present disclosure describes a pharmaceutical combination of an anti-CD20 antibody and an anti-GM-CSF antibody. Said combinations are highly efficacious in the treatment of B cell malignancies and inflammatory disorders.
Claims17
1-15. (canceled)
A method for the treatment of a patient having a B cell malignancy comprising administering to said patient a therapeutically effective amount of a combination comprising an antibody specific for CD20 and an antibody specific for GM-CSF.
A method for the treatment of a patient having an inflammatory disorder comprising administering to said patient therapeutically effective amount of a combination comprising an antibody specific for CD20 and an antibody specific for GM-CSF.
Dependencies are inferred from the claim text.